The OPEN Program is our flagship startup pre-acceleration program. During the program, founders work on market research, ideation, business planning, and product development. The programs offer hands-on workshops, support from experienced mentors, industry connections, and a shared workspace. The program culminates in a demo day event in which the founders pitch their startups to investors and other entrepreneurs

Introducing the 2022 Cohort Finalists:

ZE-o-MED is an ultrasound-based image classification tool that provides insights into the likelihood of thyroid nodules being benign.

Plantell uses genetically encoded biosensors for early stress detection in crops. These biosensors allow for real-time monitoring of the crop’s physiological state.

NucleoTech is developing drug delivery molecules that can carry therapeutics across the blood-brain barrier.

link to pitch deck

Gamila Therapeutics genetically engineers immune cells to detect the presence of specific cancer-related molecules in the bloodstream, travel toward the origin of these molecules where they can recognize and kill cancer cells.

Azteculture aims to empower farmers to cultivate exotic, high-value crops such as Cacao, Vanilla, and Saffron.

Count in is a digital platform and marketplace for inmates and their families, enabling them to better communicate with their loved ones while supporting societal re-integration upon release from prison.

LaborLead seeks to improve the birth experience and its results for women who are under epidural anesthesia.

Syntra developed tailor-made AI-based services that automatically plan and optimize education institutions' scheduling in less than 1% of the time it takes them today.

Optimal C is developing a consumption management platform that will allow anyone to automatically and easily improve their expenses and save their time and money.